85
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Relationships between expression of BCS1L, mitochondrial bioenergetics, and fatigue among patients with prostate cancer

, , , , , & show all
Pages 6703-6717 | Published online: 18 Jul 2019

References

  • American Cancer Society. Cancer facts & figures 2019-American Cancer Society; 2019 Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdf. Accessed 216, 2019.
  • Horwich A, Hugosson J, de Reijke T, Wiegel T, Fizazi K, Kataja V. Prostate cancer: ESMO consensus conference guidelines 2012. Ann Oncol, 2013;24(5):1141–1162 doi: 10.1093/annonc/mds62423303340
  • Langston B, Armes J, Levy A, Tidey E, Ream E. The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature. Support Care Cancer. 2013;21(6):1761–1771.23455492
  • Brix C, Schleussner C, Fuller J, Rohrig B, Strauss B. [Fatigue and its determinants in radio-oncology]. Psychother Psychosom Med Psychol. 2009;59(2):42–49. doi:10.1055/s-2008-106734118401851
  • Wang XS, Zhao F, Fisch MJ, et al. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivor. Cancer. 2014;120(3):425–432. doi:10.1002/cncr.2843424436136
  • Wang XS. Pathophysiology of cancer-related fatigue. Clin J Oncol Nurs. 2008;12(5 Suppl):11–20. doi:10.1188/08.CJON.S2.11-20
  • Minton O, Berger A, Barsevick A, et al. Cancer‐related fatigue and its impact on functioning. Cancer. 2013;119(S11):2124–2130. doi:10.1002/cncr.2805823695924
  • Bower JE. Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11(10):597–609. doi:10.1038/nrclinonc.2014.12725113839
  • Danjoux C, Gardner S, Fitch M. Prospective evaluation of fatigue during a course of curative radiotherapy for localised prostate cancer. Support Care Cancer. 2007;15(10):1169–1176. doi:10.1007/s00520-007-0229-817333296
  • Shaitelman SF, Schlembach PJ, Arzu I, et al. Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial. JAMA Oncol. 2015;1(7):931–941. doi:10.1001/jamaoncol.2015.266626247543
  • National Comprehensive Cancer Network. Cancer-Related Fatigue. National Compr Cancer Network Pract Guide Oncol. 2018;1;1–64.
  • Piper BF, Cella D. Cancer-related fatigue: definitions and clinical subtypes. J Natl Compr Canc Netw. 2010;8(8):958–966.20870639
  • Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the scale of the problem. Oncologist. 2007;12 Suppl 1(Suppl 1):4–10. doi:10.1634/theoncologist.12-S1-417573451
  • Byar KL, Berger AM, Bakken SL, Cetak MA. Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nurs Forum. 2006;33(1):E18–E26. doi:10.1188/06.ONF.E18-E2616470230
  • Berger AM, Mitchell SA. Modifying cancer-related fatigue by optimizing sleep quality. J Natl Compr Canc Netw. 2008;6(1):3–13.18267055
  • Monga U, Kerrigan AJ, Thornby J, Monga TN. Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiat Oncol Investig. 1999;7(3):178–185. doi:10.1002/(SICI)1520-6823(1999)7:3<178::AID-ROI7>3.0.CO;2-0
  • Pinto BM, Dunsiger S, Waldemore M. Physical activity and psychosocial benefits among breast cancer patients. Psycho-Oncol. 2013;22(10):2193–2199. doi:10.1002/pon.3272
  • Feng LR, Wolff BS, Lukkahatai NP, Espina AB, Saligan LN. Exploratory investigation of early biomarkers for chronic fatigue in prostate cancer patients following radiation therapy. Cancer Nurs. 2017;40(3):184–193. doi:10.1097/NCC.000000000000038127105468
  • Conaglen HM, de Jong D, Hartopeanu C, Conaglen JV, Tyrie LK. The effect of high dose rate brachytherapy in combination with external beam radiotherapy on men’s health-related quality of life and sexual function over a 2 year time span. Clin Oncol (R Coll Radiol). 2013;25(3):197–204. doi:10.1016/j.clon.2012.10.01223183305
  • Miaskowski C, Paul SM, Cooper BA, et al. Trajectories of fatigue in men with prostate cancer before, during, and after radiation therapy. J Pain Symptom Manage. 2008;35(6):632–643. doi:10.1016/j.jpainsymman.2007.07.00718358683
  • Hsiao C-P, Wang D, Kaushal A, Saligan L. Mitochondria-related gene expression changes are associated with fatigue in patients with nonmetastatic prostate cancer receiving external beam radiation therapy. Cancer Nurs. 2013;36(3):189–197. doi:10.1097/NCC.0b013e318263f51423047795
  • St Pierre BA, Kasper CE, Lindsey AM. Fatigue mechanisms in patients with cancer: effects of tumor necrosis factor and exercise on skeletal muscle. Oncol Nurs Forum. 1992;19(3):419–425.1594464
  • Monga U, Jaweed M, Kerrigan AJ, et al. Neuromuscular fatigue in prostate cancer patients undergoing radiation therapy. Arch Phys Med Rehabil. 1997;78(9):961–966.9305269
  • Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer-related fatigue. Oncologist. 2007;12(suppl 1):22–34. doi:10.1634/theoncologist.12-S1-22
  • Yavuzsen T, Davis MP, Ranganathan VK, et al. Cancer-related fatigue: central or peripheral? J Pain Symptom Manage. 2009;38(4):587–596. doi:10.1016/j.jpainsymman.2008.12.00319515528
  • Saligan LN, Hsiao CP, Wang D, et al. Upregulation of alpha-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways. Brain Behav Immun. 2013;27(1):63–70. doi:10.1016/j.bbi.2012.09.00923022913
  • Bower JE, Ganz PA, Tao ML, et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res. 2009;15(17):5534–5540. doi:10.1158/1078-0432.CCR-08-258419706826
  • Bower JE, Ganz PA, Irwin MR, Arevalo JM, Cole SW. Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav Immun. 2011;25(1):147–150. doi:10.1016/j.bbi.2010.09.01020854893
  • Orre IJ, Reinertsen KV, Aukrust P, et al. Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors. J Psychosom Res. 2011;71(3):136–141. doi:10.1016/j.jpsychores.2011.04.00321843747
  • Okunieff P, Chen Y, Maguire DJ, Huser AK. Molecular markers of radiation-related normal tissue toxicity. Cancer Metastasis Rev. 2008;27(3):363–374. doi:10.1007/s10555-008-9138-718506399
  • Voss JG, Dodd M, Portillo C, Holzemer W. Theories of fatigue: application in HIV/AIDS. J Assoc Nurses AIDS Care. 2006;17(1):37–50. doi:10.1016/j.jana.2005.11.004
  • Wang X. Pathophysiology of cancer-related fatigue. Clin J Oncol Nurs. 2008;12(5 Suppl):11–20. doi:10.1188/08.CJON.S2.11-20
  • Bower JE. Cancer-related fatigue-mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11:597–609. doi:10.1038/nrclinonc.2014.12725113839
  • Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol. 2011;29(26):3517–3522. doi:10.1200/JCO.2011.36.115421825266
  • Wang XS, Williams LA, Krishnan S, et al. Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy. Brain Behav Immun. 2012;26(5):699–705. doi:10.1016/j.bbi.2011.12.00722251605
  • Mills PJ, Parker B, Dimsdale JE, Sadler GR, Ancoli-Israel S. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biol Psychol. 2005;69(1):85–96. doi:10.1016/j.biopsycho.2004.11.00715740827
  • Geinitz H, Zimmermann FB, Stoll P, et al. Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):691–698. doi:10.1016/S0360-3016(01)01657-111597810
  • Pusztai L, Mendoza TR, Reuben JM, et al. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine. 2004;25(3):94–102.14698135
  • Reinertsen KV, Grenaker Alnaes GI, Landmark-Høyvik H, et al. Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway. Brain Behav Immun. 2011;25(7):1376–1383. doi:10.1016/j.bbi.2011.04.00121496483
  • Hsiao CP, Wang D, Kaushal A, Saligan L. Mitochondria-related gene expression changes are associated with fatigue in patients with nonmetastatic prostate cancer receiving external beam radiation therapy. Cancer Nur. 2012;36(3):189–197.
  • Hsiao C-P, Wang D, Kaushal A, Chen M-K SL. Differential expression of genes related to mitochondrial biogenesis and bioenergetics in fatigued prostate cancer men receiving external beam radiation therapy. J Pain Symptom Manage. 2014;48(6):1080–1090. doi:10.1016/j.jpainsymman.2014.03.01024786901
  • Hsiao C-P, Chen M-K, Daly B, Hoppel C. Integrated mitochondrial function and cancer-related fatigue in men with prostate cancer undergoing radiation therapy. Cancer Manag Res. 2018;10:6367–6377. doi:10.2147/CMAR.S18570630568498
  • Hsiao C-P, Daly B, Hoppel C. Association between mitochondrial bioenergetics and radiation-related fatigue: a possible mechanism and novel target. Archives in Cancer Research. 2015;3(2):14. doi:10.21767/2254-6081.100014
  • Hsiao CP, Hoppel C. Analyzing mitochondrial function in human peripheral blood mononuclear cells. Anal Biochem. 2018;549:12–20. doi:10.1016/j.ab.2018.03.00329505781
  • Davis RE, Williams M. Mitochondrial function and dysfunction: an update. J Pharmacol Exp Ther. 2012;342(3):598–607. doi:10.1124/jpet.112.19210422700430
  • Puchowicz MA, Varnes ME, Cohen BH, Friedman NR, Kerr DS, Hoppel CL. Oxidative phosphorylation analysis: assessing the integrated functional activity of human skeletal muscle mitochondria–case studies. Mitochondrion. 2004;4(5–6):377–385. doi:10.1016/j.mito.2004.07.00416120399
  • Hinson JT, Fantin VR, Schönberger J, et al. Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome. N Engl J Med. 2007;356(8):809–819. doi:10.1056/NEJMoa05526217314340
  • Mandelker L. Introduction to oxidative stress and mitochondrial dysfunction. Vet Clin North Am Small Anim Pract. 2008;38(1):1–30. doi:10.1016/j.cvsm.2007.10.00518249243
  • Piper BF. Piper fatigue scale available for clinical testing. Oncol Nurs Forum. 1990;17(5):661–662.
  • Stover AM, Reeve BB, Piper BF, et al. Deriving clinically meaningful cut-scores for fatigue in a cohort of breast cancer survivors: a Health, Eating, Activity, and Lifestyle (HEAL) Study. Qual Life Res. 2013;22(9):2279–2292. doi:10.1007/s11136-013-0360-623420495
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. doi:10.1136/jnnp.23.1.5614399272
  • Lydiatt WM, Denman D, McNeilly DP, Puumula SE, Burke WJ. A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer. Arch Otolaryngol Head Neck Surg. 2008;134(5):528–535. doi:10.1001/archotol.134.5.52818490576
  • Ye F, Hoppel CL. Measuring oxidative phosphorylation in human skin fibroblasts. Anal Biochem. 2013;437(1):52–58. doi:10.1016/j.ab.2013.02.01023462540
  • Hoppel CL, Kerr DS, Dahms B, Roessmann U. Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of mitochondrial electron transport. Fatal infantile lactic acidosis and hypermetabolism with skeletal-cardiac myopathy and encephalopathy. J Clin Invest. 1987;80(1):71–77. doi:10.1172/JCI1130663110216
  • Krahenbuhl S, Chang M, Brass EP, Hoppel CL. Decreased activities of ubiquinol: ferricytochromec oxidoreductase (complex III) and ferrocytochrome c: oxygenoxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[c-lactam]-induced methylmalonic aciduria. J Biol Chem. 1991;266(31):20998–21003.1657942
  • Krähenbühl S, Talos C, Wiesmann U, Hoppel CL. Development and evaluation of a spectrophotometric assay for complex III in isolated mitochondria, tissues and fibroblasts from rats and humans. Clin Chim Acta. 1994;230(2):177–187. doi:10.1016/0009-8981(94)90270-47834868
  • Pesta D, Gnaiger E. High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol. 2012;810:25–58. doi:10.1007/978-1-61779-382-0_322057559
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein Measurement with the Folin Phenol Reagent. J Biol Chem. 1951;193(1):265–275.14907713
  • Hoppel C, Cooper C. An improved procedure for preparation of inner membrane vesicles from rat liver mitochondria by treatment with digitonin. Arch Biochem Biophys. 1969;135(1):173–183.4312068
  • Krahenbuhl S, Talos C, Wiesmann U, Hoppel CL. Development and evaluation of a spectrophotometric assay for complex III in isolated mitochondria, tissues and fibroblasts from rats and humans. Clin Chim Acta. 1994;230(2):177–187.7834868
  • Slater EC. The measurement of the cytochrome oxidase activity of enzyme preparations. Biochem J. 1949;44(3):305. doi:10.1042/bj044030516748521
  • Lazure KE, Lydiatt WM, Denman D, Burke WJ. Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial. Head Neck. 2009;31(7):888–892. doi:10.1002/hed.v31:719309726
  • Puchowicz MA, Varnes ME, Cohen BH, Friedman NR, Kerr DS, Hoppel CL. Oxidative phosphorylation analysis: assessing the integrated functional activity of human skeletal muscle mitochondria—case studies. Mitochondrion. 2004;4(5):377–385. doi:10.1016/j.mito.2004.07.00416120399
  • Borisov VB, Liebl U, Rappaport F, et al. Interactions between heme d and heme b595 in quinol oxidase bd from Escherichia coli: a photoselection study using femtosecond spectroscopy. Biochemistry. 2002;41(5):1654–1662.11814360
  • Meunier B, Fisher N, Ransac S, Mazat JP, Brasseur G. Respiratory complex III dysfunction in humans and the use of yeast as a model organism to study mitochondrial myopathy and associated diseases. Biochim Biophys Acta. 2013;1827(11–12):1346–1361. doi:10.1016/j.bbabio.2012.11.01523220121
  • Hinson JT, Fantin VR, Schonberger J, et al. Missense mutations in the BCS1L gene as a cause of the Bjornstad syndrome. N Engl J Med. 2007;356(8):809–819. doi:10.1056/NEJMoa05526217314340
  • Feng L, Chen M-K, Lukkahatai N, et al. Clinical predictors of fatigue in men with non-metastatic prostate cancer receiving external beam radiation therapy. Clin J Oncol Nurs. 2015;19(6):744–750. doi:10.1188/15.CJON.744-75026583638